Erythromycin-induced polymorphous ventricular tachycardia with normal QT interval

American Heart Journal

Volumn 132, Issue 3, 1996, Pages 691-694

  Chennareddy, Sudhakara B ^a   Siddique, Mohamed ^a   Karim, Muhammad Y ^a   Kudesia, Vijay ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Grace Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ELECTROCARDIOGRAM; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; PRIORITY JOURNAL; QT INTERVAL; TORSADE DES POINTES;

EID: 0029955454     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90258-6     Document Type: Article

References (11)

1. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long QT syndromes. A critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988;31:115-72.
2. Gitler B, Berger LS, Buffa SD. Torsades de pointes induced by erythromycin. Chest 1994;105:368-72.
3. Freedman RA, Anderson KP, Green LS, Mason JW. Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol 1987;59:168-9.
4. Guelon D, Bedock B, Chartier C, Harberer J. QT prolongation and recurrent torsades de pointes during erythromycin lactobionate infusion. Am J Cardiol 1986;58:666.
5. + transport and the production of ventricular tachycardia. J Clin Invest 1969;48:68a.
6. Ponsonnaille J, Citron B, Richard A, et al. An electrophysiological study of the arrhythmogenic effects of erythromycin. Arch Mal Coeur 1988; 81:1001-8.
7. Nattel S, Ranger S, Talajic M, Lemery R, Roy D. Erythromycin induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism. Am J Med 1990;89:235-8.
8. Rubart M, Pressler ML, Pride HP, Zipes DP. Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome. Circulation 1993;88:1832-44.
9. Kay GN, Plumb VJ, Arciniegas JG, Henthron RW, Waldo AL. Torsades de pointes: the long-short initiating sequence and other clinical features. Observations in 32 patients. J Am Coll Cardiol 1983;2:806-17.
10. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR Jr. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concommitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-8.
11. Ragosta M, Weihl AC, Rosenfeld LE. Potentially fatal interaction between erythromycin and disopyramide. Am J Med 1989;86:464-6.